$11.13
+0.56
(+5.3%)▲
Live
4.13%
Downside
Day's Volatility :5.91%
Upside
1.85%
34.68%
Downside
52 Weeks Volatility :55.78%
Upside
32.3%
Period | Gohealth, Inc. | Russel 2000 | Index (Russel 2000) |
---|---|---|---|
3 Months | -24.07% | 0.0% | 0.0% |
6 Months | 8.52% | 0.0% | 0.0% |
1 Year | -13.57% | 0.0% | 0.0% |
3 Years | -87.91% | -23.0% | -23.0% |
Market Capitalization | 219.7M |
Book Value | $20.15 |
Earnings Per Share (EPS) | -6.54 |
Wall Street Target Price | 17.67 |
Profit Margin | -8.62% |
Operating Margin TTM | -38.36% |
Return On Assets TTM | -2.63% |
Return On Equity TTM | -31.31% |
Revenue TTM | 700.2M |
Revenue Per Share TTM | 72.25 |
Quarterly Revenue Growth YOY | -25.900000000000002% |
Gross Profit TTM | 444.0M |
EBITDA | 40.3M |
Diluted Eps TTM | -6.54 |
Quarterly Earnings Growth YOY | 4.24 |
EPS Estimate Current Year | -5.37 |
EPS Estimate Next Year | -4.31 |
EPS Estimate Current Quarter | -2.47 |
EPS Estimate Next Quarter | -2.52 |
What analysts predicted
Upside of 58.76%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 226.2M | - |
Net Income | 28.1M | - |
Net Profit Margin | 12.43% | - |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 539.5M | ↑ 138.5% |
Net Income | -41.1M | ↓ 246.06% |
Net Profit Margin | -7.61% | ↓ 20.04% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 877.4M | ↑ 62.62% |
Net Income | -97.2M | ↑ 136.68% |
Net Profit Margin | -11.08% | ↓ 3.47% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 1.1B | ↑ 21.09% |
Net Income | -534.2M | ↑ 449.58% |
Net Profit Margin | -50.28% | ↓ 39.2% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 631.7M | ↓ 40.54% |
Net Income | -376.4M | ↓ 29.54% |
Net Profit Margin | -59.59% | ↓ 9.31% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 734.7M | ↑ 16.31% |
Net Income | -63.3M | ↓ 83.19% |
Net Profit Margin | -8.61% | ↑ 50.98% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 183.2M | ↑ 164.01% |
Net Income | -22.5M | ↓ 85.04% |
Net Profit Margin | -12.31% | ↑ 204.97% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 142.8M | ↓ 22.05% |
Net Income | -28.9M | ↑ 28.39% |
Net Profit Margin | -20.27% | ↓ 7.96% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 132.0M | ↓ 7.52% |
Net Income | -23.9M | ↓ 17.39% |
Net Profit Margin | -18.11% | ↑ 2.16% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 276.7M | ↑ 109.56% |
Net Income | -1.2M | ↓ 94.87% |
Net Profit Margin | -0.44% | ↑ 17.67% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 185.6M | ↓ 32.92% |
Net Income | -9.2M | ↑ 651.71% |
Net Profit Margin | -4.97% | ↓ 4.53% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 105.9M | ↓ 42.96% |
Net Income | -26.0M | ↑ 182.07% |
Net Profit Margin | -24.55% | ↓ 19.58% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 142.8M | - |
Total Liabilities | 329.5M | - |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 1.6B | ↑ 1021.76% |
Total Liabilities | 742.2M | ↑ 125.24% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 2.1B | ↑ 31.61% |
Total Liabilities | 709.6M | ↓ 4.38% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 2.1B | ↓ 1.89% |
Total Liabilities | 1.2B | ↑ 65.77% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 1.7B | ↓ 19.8% |
Total Liabilities | 1.1B | ↓ 9.25% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 1.5B | ↓ 9.63% |
Total Liabilities | 1.1B | ↑ 2.47% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.5B | ↓ 6.98% |
Total Liabilities | 970.9M | ↓ 9.06% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.5B | ↓ 3.97% |
Total Liabilities | 972.2M | ↑ 0.14% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.4B | ↓ 3.03% |
Total Liabilities | 983.5M | ↑ 1.16% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.5B | ↑ 4.32% |
Total Liabilities | 1.1B | ↑ 11.23% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 1.4B | ↓ 6.96% |
Total Liabilities | 1.0B | ↓ 7.71% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 1.3B | ↓ 9.9% |
Total Liabilities | 929.3M | ↓ 7.96% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 5.4M | - |
Investing Cash Flow | -6.2M | - |
Financing Cash Flow | 63.0K | - |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -3.0K | ↓ 100.06% |
Investing Cash Flow | -815.6M | ↑ 13118.91% |
Financing Cash Flow | 827.4M | ↑ 1313280.95% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -114.2M | ↑ 3807133.33% |
Investing Cash Flow | -14.5M | ↓ 98.22% |
Financing Cash Flow | 260.7M | ↓ 68.5% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -299.0M | ↑ 161.79% |
Investing Cash Flow | -19.8M | ↑ 36.34% |
Financing Cash Flow | 259.1M | ↓ 0.6% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 60.9M | ↓ 120.37% |
Investing Cash Flow | -13.5M | ↓ 31.76% |
Financing Cash Flow | -115.1M | ↓ 144.41% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 20.5M | ↓ 149.95% |
Investing Cash Flow | -2.2M | ↑ 57.2% |
Financing Cash Flow | -2.4M | ↓ 98.47% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 10.9M | ↓ 46.97% |
Investing Cash Flow | -2.4M | ↑ 9.34% |
Financing Cash Flow | -15.4M | ↑ 543.68% |
Sell
Neutral
Buy
Gohealth, Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Gohealth, Inc. | 10.8% | 8.52% | -13.57% | -87.91% | -96.38% |
Willis Towers Watson Plc | -0.28% | 9.38% | 42.5% | 17.48% | 52.61% |
Marsh & Mclennan Companies, Inc. | 0.04% | 11.53% | 20.51% | 33.38% | 125.25% |
Arthur J Gallagher & Co. | 2.56% | 21.78% | 27.03% | 76.95% | 220.21% |
Aon Plc | 2.7% | 15.08% | 14.18% | 12.06% | 83.53% |
Brown & Brown Inc. | 4.09% | 28.96% | 59.31% | 62.11% | 190.52% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Gohealth, Inc. | NA | NA | NA | -5.37 | -0.31 | -0.03 | NA | 20.15 |
Willis Towers Watson Plc | 28.08 | 28.08 | 1.09 | 16.43 | 0.11 | 0.04 | 0.01 | 91.95 |
Marsh & Mclennan Companies, Inc. | 28.12 | 28.12 | 2.43 | 8.75 | 0.32 | 0.08 | 0.01 | 24.78 |
Arthur J Gallagher & Co. | 56.49 | 56.49 | 1.03 | 10.14 | 0.1 | 0.03 | 0.01 | 52.82 |
Aon Plc | 28.75 | 28.75 | 1.7 | 15.25 | 0.82 | 0.06 | 0.01 | 26.98 |
Brown & Brown Inc. | 30.57 | 30.57 | 4.41 | 3.72 | 0.18 | 0.05 | 0.0 | 21.14 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Gohealth, Inc. | Buy | $219.7M | -96.38% | NA | -8.62% |
Willis Towers Watson Plc | Buy | $29.6B | 52.61% | 28.08 | 11.24% |
Marsh & Mclennan Companies, Inc. | Hold | $111.6B | 125.25% | 28.12 | 16.97% |
Arthur J Gallagher & Co. | Buy | $63.4B | 220.21% | 56.49 | 10.98% |
Aon Plc | Hold | $77.8B | 83.53% | 28.75 | 18.0% |
Brown & Brown Inc. | Buy | $30.3B | 190.52% | 30.57 | 22.33% |
Insights on Gohealth, Inc.
Revenue is down for the last 3 quarters, 276.69M → 105.87M (in $), with an average decrease of 37.9% per quarter
Netprofit is down for the last 3 quarters, -1.22M → -25.99M (in $), with an average decrease of 416.9% per quarter
In the last 1 year, Brown & Brown Inc. has given 58.4% return, outperforming this stock by 71.3%
In the last 3 years, Arthur J Gallagher & Co. has given 62.1% return, outperforming this stock by 150.0%
Centerbridge Partners, L.P.
BlackRock Inc
Vanguard Group Inc
CI Private Wealth LLC
Geode Capital Management, LLC
Blue Owl Capital Holdings LP
Organization | Gohealth, Inc. |
Employees | 2530 |
CEO | Mr. Brandon M. Cruz |
Industry | Finance |
Jpmorgan Betabuilders 1-5 Year Us Aggregate Bd Etf
$11.13
+5.3%
Invesco Bulletshares 2025 Hi
$11.13
+5.3%
Schwab International Dividend Equity Etf
$11.13
+5.3%
Blockchain Coinvestors Acquisition Corp.
$11.13
+5.3%
Allgiant Travel Company
$11.13
+5.3%
Rogers Corp
$11.13
+5.3%
Innovator Intl Developed 10 Buffer Etf - Quarterly
$11.13
+5.3%
Iheartmedia
$11.13
+5.3%
Lightpath Technologies Inc
$11.13
+5.3%